Current Liabilities Changement Date
Acadia Pharmaceuticals USD 254.25M 44.65M 2023-12
Adcock Ingram Holdings ZAR 2.43B 315.8M 2023-06
Agios Pharmaceuticals USD 67.96M 9.53M 2023-12
Alnylam Pharmaceuticals USD 967.79M 18M 2023-12
Amgen USD 18.39B 1.44B 2023-12
Arrowhead Research USD 63.72M 41.73M 2023-12
Biogen USD 3.43B 1.59B 2023-12
BioMarin Pharmaceutical USD 1.18B 13.8M 2023-12
Bluebird Bio USD 158.96M 23.94M 2023-09
Celltrion KRW 1.82T 234.21B 2023-09
Deva Holding AS TRY 6.43B 1.18B 2023-09
Esperion Therapeutics USD 137.71M 30.54M 2023-09
Gilead Sciences USD 11.28B 665M 2023-12
GlaxoSmithKline GBP 22.39B 282M 2023-09
Incyte USD 1.24B 115.7M 2023-12
Ionis Pharmaceuticals USD 448.09M 43.88M 2023-12
Kangmei Pharma CNY 5.15B 126.26M 2023-09
Knight Therapeutics CAD 115.08M 6.92M 2023-09
Laboratorios Farma EUR 321.59M 27.71M 2023-06
Magenta Therapeutics USD 13.08M 9.04M 2023-09
Malin Corporation EUR 1.3M 700K 2023-06
Moderna USD 3.02B 1.37B 2023-12
Organigram Holdings CAD 39.77M 8.36M 2023-03
Ovoca Bio EUR 2.44M 1.1M 2022-06
Pharma Mar EUR 86.62M 1.12M 2023-09
Qiagen NV USD 524.37M 454.08M 2023-09
Regeneron Pharmaceuticals USD 4.4B 805.6M 2023-12
Sarepta Therapeutics USD 450.74M 47.91M 2023-09
Sartorius EUR 1.35B 263.6M 2023-09
Sino Biopharmaceutical CNY 26.87B 6.71B 2023-06
Ultragenyx Pharmaceutical USD 253.98M 9.6M 2023-09
United Therapeutics USD 804.4M 60.3M 2023-12
Vertex Pharmaceuticals USD 3.6B 247.3M 2023-09
Zz Pientze Pharmaceu 2.26B 708M 2023-09



Moderna Passifs Courants - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Apr 2024.